| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.00018 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -8.3e-05 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 6.2e-05 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -2.9e-05 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -1.1e-05 | 1 |